UK markets closed

Senseonics Holdings, Inc. (SENS)

NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
1.0200-0.0100 (-0.97%)
At close: 04:00PM EDT
1.0400 +0.02 (+1.96%)
After hours: 07:51PM EDT
Full screen
Loading interactive chart…
  • Business Wire

    Senseonics Announces CE Mark Approval of the Eversense E3 Continuous Glucose Monitoring System

    GERMANTOWN, Md., June 16, 2022--Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it has received CE Mark approval for the next-generation Eversense® E3 CGM System, the longest-lasting system available, with exceptional accuracy. The CE Mark approval confirms that the Eversense E3 meets the requirements of the

  • Business Wire

    Senseonics to Participate in the Jefferies Healthcare Conference

    GERMANTOWN, Md., May 26, 2022--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming Jefferies Healthcare Conference in New York, NY.

  • Business Wire

    Senseonics to Participate in the H.C. Wainwright Global Investment Conference

    GERMANTOWN, Md., May 16, 2022--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming hybrid H.C. Wainwright Global Investment Conference.